IL37 and acute coronary syndrome: As demonstrated by clinical and and pre-clinical studies in animal models, IL-37 participates in atherosclerotic disease and its levels are highly upregulated in acute coronary syndrome in which increased IL-37 levels are correlated with poor outcomes [94,95].